LUKE EVNIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is Director in OSCIENT PHARMACEUTICALS CORP ($GENE) and 10% Owner in VIACELL INC ($VIAC) and in BARRIER THERAPEUTICS INC ($BTRX) and 10% Owner in BARRIER THERAPEUTICS INC ($BTRX) and 10% Owner in TERCICA INC ($TRCA) and 10% Owner in COTHERIX INC ($CTRX) and Director in METABASIS THERAPEUTICS INC ($MBRX).
Latest Insider Trading Transactions of LUKE EVNIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BTRX, CTRX, MBRX, GENE, TRCA, VIAC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 04 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | P | 6.74 | 244,881 | 1,650,498 | 244,881 | |
Oct 04 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Sell | P | 5.86 | 699,659 | 4,100,002 | 4,497,978 | 5.2 M to 4.5 M (-13.46 %) |
Oct 19 2005 | CTRX | COTHERIX INC | EVNIN LUKE | 10% Owner | Sell | S | 13.00 | 170,563 | 2,217,319 | 3,572,555 | 3.7 M to 3.6 M (-4.56 %) |
Oct 13 2005 | CTRX | COTHERIX INC | EVNIN LUKE | 10% Owner | Sell | S | 13.00 | 252,686 | 3,284,918 | 3,743,118 | 4 M to 3.7 M (-6.32 %) |
Sep 12 2005 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Sell | S | 12.00 | 8,400 | 100,800 | 6,861,268 | 6.9 M to 6.9 M (-0.12 %) |
Sep 07 2005 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Sell | S | 12.01 | 98,196 | 1,179,157 | 6,869,668 | 7 M to 6.9 M (-1.41 %) |
Sep 07 2005 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Sell | S | 12.49 | 96,630 | 1,206,735 | 6,967,864 | 7.1 M to 7 M (-1.37 %) |
Sep 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.41 | 40,000 | 96,324 | 4,021,075 | 4.1 M to 4 M (-0.98 %) |
Sep 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.41 | 105,000 | 252,588 | 4,061,075 | 4.2 M to 4.1 M (-2.52 %) |
Sep 14 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.45 | 23,975 | 58,756 | 4,166,075 | 4.2 M to 4.2 M (-0.57 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.44 | 50,000 | 121,855 | 4,190,050 | 4.2 M to 4.2 M (-1.18 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.44 | 205,000 | 500,938 | 4,240,050 | 4.4 M to 4.2 M (-4.61 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.51 | 100,000 | 250,980 | 4,445,050 | 4.5 M to 4.4 M (-2.20 %) |
Sep 08 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.58 | 42,000 | 108,486 | 4,545,050 | 4.6 M to 4.5 M (-0.92 %) |
Sep 08 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.47 | 200,000 | 493,560 | 4,587,050 | 4.8 M to 4.6 M (-4.18 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.35 | 500,000 | 1,175,000 | 4,787,050 | 5.3 M to 4.8 M (-9.46 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 1,000,000 | 2,300,000 | 5,287,050 | 6.3 M to 5.3 M (-15.91 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.28 | 100,000 | 228,000 | 6,287,050 | 6.4 M to 6.3 M (-1.57 %) |
Aug 25 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.23 | 200,000 | 446,000 | 6,387,050 | 6.6 M to 6.4 M (-3.04 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.28 | 150,000 | 342,000 | 6,587,050 | 6.7 M to 6.6 M (-2.23 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.29 | 50,000 | 114,680 | 6,737,050 | 6.8 M to 6.7 M (-0.74 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.42 | 100,000 | 242,000 | 6,787,050 | 6.9 M to 6.8 M (-1.45 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.35 | 60,000 | 141,168 | 6,887,050 | 6.9 M to 6.9 M (-0.86 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.53 | 225,000 | 569,160 | 6,947,050 | 7.2 M to 6.9 M (-3.14 %) |
May 19 2005 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 2.65 | 10,000 | 26,500 | 10,000 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | P | 5.00 | 1,213 | 6,065 | 1,213 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | P | 5.00 | 12,620 | 63,100 | 12,620 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | P | 5.00 | 111,167 | 555,835 | 111,167 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 125,000 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 235,274 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 470,155 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 1,666,667 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 666,667 | 0 | 0 | |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 235,274 | 0 | 235,274 | 0 to 235.3 K |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 125,000 | 0 | 4,928,489 | 4.8 M to 4.9 M (+2.60 %) |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 470,155 | 0 | 4,803,489 | 4.3 M to 4.8 M (+10.85 %) |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 2,000,000 | 0 | 4,333,334 | 2.3 M to 4.3 M (+85.71 %) |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,666,667 | 0 | 2,333,334 | 666.7 K to 2.3 M (+250.00 %) |
Jan 28 2005 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 666,667 | 0 | 666,667 | 0 to 666.7 K |
Mar 03 2005 | BTRX | BARRIER THERAPEUTI ... | EVNIN LUKE | Sell | S | 19.50 | 384,236 | 7,492,602 | 1,946,788 | 2.3 M to 1.9 M (-16.48 %) | |
Dec 22 2004 | BTRX | BARRIER THERAPEUTI ... | EVNIN LUKE | 10% Owner | Sell | S | 17.90 | 10,000 | 179,001 | 2,331,024 | 2.3 M to 2.3 M (-0.43 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 9.11 | 217,780 | 1,984,520 | 217,780 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 6.08 | 450,979 | 2,739,697 | 450,979 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 1.50 | 1,262,295 | 1,893,443 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 1.00 | 2,739,711 | 2,739,711 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 6,923,077 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 5,737,704 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 7,969,230 | 0 | 0 | |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | P | 7.00 | 357,000 | 2,499,000 | 3,798,319 | 3.4 M to 3.8 M (+10.37 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,139,599 | 0 | 3,441,319 | 2.3 M to 3.4 M (+49.51 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 989,914 | 0 | 2,301,720 | 1.3 M to 2.3 M (+75.46 %) |
Jun 21 2004 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,311,806 | 0 | 1,311,806 | 0 to 1.3 M |
May 05 2004 | BTRX | BARRIER THERAPEUTI ... | EVNIN LUKE | 10% Owner | Buy | P | 15.00 | 200,000 | 3,000,000 | 2,341,024 | 2.1 M to 2.3 M (+9.34 %) |
Apr 29 2004 | BTRX | BARRIER THERAPEUTI ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 4,282,050 | 0 | 0 | |
Apr 29 2004 | BTRX | BARRIER THERAPEUTI ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 2,141,024 | 0 | 2,141,024 | 0 to 2.1 M |
Mar 23 2004 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 3,199,999 | 0 | 0 | |
Mar 23 2004 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 3,187,498 | 0 | 0 | |
Mar 23 2004 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 3,199,999 | 0 | 7,062,494 | 3.9 M to 7.1 M (+82.85 %) |
Mar 23 2004 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 3,187,498 | 0 | 3,862,495 | 675 K to 3.9 M (+472.22 %) |
Mar 23 2004 | TRCA | TERCICA INC | EVNIN LUKE | 10% Owner | Buy | P | 9.00 | 670,000 | 6,030,000 | 674,997 | 5 K to 675 K (+13,408.04 %) |
Page: 1